Cargando…

Naturally-Occurring Tyrosinase Inhibitors Classified by Enzyme Kinetics and Copper Chelation

Currently, there are three major assaying methods used to validate in vitro whitening activity from natural products: methods using mushroom tyrosinase, human tyrosinase, and dopachrome tautomerase (or tyrosinase-related protein-2, TRP-2). Whitening agent development consists of two ways, melanin sy...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hee-Do, Choi, Hyunju, Abekura, Fukushi, Park, Jun-Young, Yang, Woong-Suk, Yang, Seung-Hoon, Kim, Cheorl-Ho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10178891/
https://www.ncbi.nlm.nih.gov/pubmed/37175965
http://dx.doi.org/10.3390/ijms24098226
_version_ 1785040967585234944
author Kim, Hee-Do
Choi, Hyunju
Abekura, Fukushi
Park, Jun-Young
Yang, Woong-Suk
Yang, Seung-Hoon
Kim, Cheorl-Ho
author_facet Kim, Hee-Do
Choi, Hyunju
Abekura, Fukushi
Park, Jun-Young
Yang, Woong-Suk
Yang, Seung-Hoon
Kim, Cheorl-Ho
author_sort Kim, Hee-Do
collection PubMed
description Currently, there are three major assaying methods used to validate in vitro whitening activity from natural products: methods using mushroom tyrosinase, human tyrosinase, and dopachrome tautomerase (or tyrosinase-related protein-2, TRP-2). Whitening agent development consists of two ways, melanin synthesis inhibition in melanocytes and downregulation of melanocyte stimulation. For melanin levels, the melanocyte cell line has been used to examine melanin synthesis with the expression levels of TRP-1 and TRP-2. The proliferation of epidermal surfaced cells and melanocytes is stimulated by cellular signaling receptors, factors, or mediators including endothelin-1, α-melanocyte-stimulating hormone, nitric oxide, histamine, paired box 3, microphthalmia-associated transcription factor, pyrimidine dimer, ceramide, stem cell factors, melanocortin-1 receptor, and cAMP. In addition, the promoter region of melanin synthetic genes including tyrosinase is upregulated by melanocyte-specific transcription factors. Thus, the inhibition of growth and melanin synthesis in gene expression levels represents a whitening research method that serves as an alternative to tyrosinase inhibition. Many researchers have recently presented the bioactivity-guided fractionation, discovery, purification, and identification of whitening agents. Melanogenesis inhibition can be obtained using three different methods: tyrosinase inhibition, copper chelation, and melanin-related protein downregulation. There are currently four different types of inhibitors characterized based on their enzyme inhibition mechanisms: competitive, uncompetitive, competitive/uncompetitive mixed-type, and noncompetitive inhibitors. Reversible inhibitor types act as suicide substrates, where traditional inhibitors are classified as inactivators and reversible inhibitors based on the molecule-recognizing properties of the enzyme. In a minor role, transcription factors can also be downregulated by inhibitors. Currently, the active site copper iron-binding inhibitors such as kojic acid and chalcone exhibit tyrosinase inhibitory activity. Because the tyrosinase catalysis site structure is important for the mechanism determination of tyrosinase inhibitors, understanding the enzyme recognition and inhibitory mechanism of inhibitors is essential for the new development of tyrosinase inhibitors. The present review intends to classify current natural products identified by means of enzyme kinetics and copper chelation to exhibit tyrosinase enzyme inhibition.
format Online
Article
Text
id pubmed-10178891
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-101788912023-05-13 Naturally-Occurring Tyrosinase Inhibitors Classified by Enzyme Kinetics and Copper Chelation Kim, Hee-Do Choi, Hyunju Abekura, Fukushi Park, Jun-Young Yang, Woong-Suk Yang, Seung-Hoon Kim, Cheorl-Ho Int J Mol Sci Review Currently, there are three major assaying methods used to validate in vitro whitening activity from natural products: methods using mushroom tyrosinase, human tyrosinase, and dopachrome tautomerase (or tyrosinase-related protein-2, TRP-2). Whitening agent development consists of two ways, melanin synthesis inhibition in melanocytes and downregulation of melanocyte stimulation. For melanin levels, the melanocyte cell line has been used to examine melanin synthesis with the expression levels of TRP-1 and TRP-2. The proliferation of epidermal surfaced cells and melanocytes is stimulated by cellular signaling receptors, factors, or mediators including endothelin-1, α-melanocyte-stimulating hormone, nitric oxide, histamine, paired box 3, microphthalmia-associated transcription factor, pyrimidine dimer, ceramide, stem cell factors, melanocortin-1 receptor, and cAMP. In addition, the promoter region of melanin synthetic genes including tyrosinase is upregulated by melanocyte-specific transcription factors. Thus, the inhibition of growth and melanin synthesis in gene expression levels represents a whitening research method that serves as an alternative to tyrosinase inhibition. Many researchers have recently presented the bioactivity-guided fractionation, discovery, purification, and identification of whitening agents. Melanogenesis inhibition can be obtained using three different methods: tyrosinase inhibition, copper chelation, and melanin-related protein downregulation. There are currently four different types of inhibitors characterized based on their enzyme inhibition mechanisms: competitive, uncompetitive, competitive/uncompetitive mixed-type, and noncompetitive inhibitors. Reversible inhibitor types act as suicide substrates, where traditional inhibitors are classified as inactivators and reversible inhibitors based on the molecule-recognizing properties of the enzyme. In a minor role, transcription factors can also be downregulated by inhibitors. Currently, the active site copper iron-binding inhibitors such as kojic acid and chalcone exhibit tyrosinase inhibitory activity. Because the tyrosinase catalysis site structure is important for the mechanism determination of tyrosinase inhibitors, understanding the enzyme recognition and inhibitory mechanism of inhibitors is essential for the new development of tyrosinase inhibitors. The present review intends to classify current natural products identified by means of enzyme kinetics and copper chelation to exhibit tyrosinase enzyme inhibition. MDPI 2023-05-05 /pmc/articles/PMC10178891/ /pubmed/37175965 http://dx.doi.org/10.3390/ijms24098226 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Kim, Hee-Do
Choi, Hyunju
Abekura, Fukushi
Park, Jun-Young
Yang, Woong-Suk
Yang, Seung-Hoon
Kim, Cheorl-Ho
Naturally-Occurring Tyrosinase Inhibitors Classified by Enzyme Kinetics and Copper Chelation
title Naturally-Occurring Tyrosinase Inhibitors Classified by Enzyme Kinetics and Copper Chelation
title_full Naturally-Occurring Tyrosinase Inhibitors Classified by Enzyme Kinetics and Copper Chelation
title_fullStr Naturally-Occurring Tyrosinase Inhibitors Classified by Enzyme Kinetics and Copper Chelation
title_full_unstemmed Naturally-Occurring Tyrosinase Inhibitors Classified by Enzyme Kinetics and Copper Chelation
title_short Naturally-Occurring Tyrosinase Inhibitors Classified by Enzyme Kinetics and Copper Chelation
title_sort naturally-occurring tyrosinase inhibitors classified by enzyme kinetics and copper chelation
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10178891/
https://www.ncbi.nlm.nih.gov/pubmed/37175965
http://dx.doi.org/10.3390/ijms24098226
work_keys_str_mv AT kimheedo naturallyoccurringtyrosinaseinhibitorsclassifiedbyenzymekineticsandcopperchelation
AT choihyunju naturallyoccurringtyrosinaseinhibitorsclassifiedbyenzymekineticsandcopperchelation
AT abekurafukushi naturallyoccurringtyrosinaseinhibitorsclassifiedbyenzymekineticsandcopperchelation
AT parkjunyoung naturallyoccurringtyrosinaseinhibitorsclassifiedbyenzymekineticsandcopperchelation
AT yangwoongsuk naturallyoccurringtyrosinaseinhibitorsclassifiedbyenzymekineticsandcopperchelation
AT yangseunghoon naturallyoccurringtyrosinaseinhibitorsclassifiedbyenzymekineticsandcopperchelation
AT kimcheorlho naturallyoccurringtyrosinaseinhibitorsclassifiedbyenzymekineticsandcopperchelation